Next report date
Report period
Q1 2024
EPS estimate
0.75EUR
Revenue estimate
854.39 MEUR
2.42EUR
541.43 MEUR
3.35 BEUR
221.84 M
About Incyte Corporation
Sector
CEO
Herve Hoppenot
Headquarters
Wilmington
Website
Employees (FY)
2.52 K
Founded
1991
FIGI
BBG01K3XHTS6
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
INCY setting up for a Base BreakoutINCY has been basing for a few months under this $66 level
Keep an eye out for the exit of the stage 1 base into a stage 2 breakout through $66 to the upside
INCY - Incyte Bullish BreakoutOn this 5 Month Daily Chart of Incyte you can clearly see the Bearish Trend that included the last 6 weeks of each daily candle trending below the 7 Day EMA until just the last 2 trading days where the bottom was made and INCY finally broke above the 7 day EMA on very good strenth with much higher v
INCY Buy Opportunity "Pause Rebounders "Pause Rebounder Stock
Market Watch:
Because until equity markets begin to notice. it’s unlikely politicians will feel compelled to act. Political brinkmanship will fuel market volatility — the VIX (VIX) trades to 40 in 2023; SPX retests the 3,800 floor. The similarities to 2011 (where arguably Dem
$INCY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $INCY after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 85.71%.
$INCY with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $INCY after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 100%.
WATCH $INCY CUP AND HANDLEBullish
Fundamental
- High inflationary Macro environment / still no fear form retail sentiment
- Decent Accumulation/Distribution
- Decent PE
- Decent PEG
- Decent P/FCF
- Top Sector / Industry
- Fundamental sound company with a Cup and handle play / short term
Technical
- Momentum Theory Indi
INCY - Bearish ActionI expect INCY to show bearish traits following this post
As price moves along the bearish red trend line
This bearish action may stop along the dotted white line, this would be the better entry for INCY
$INCY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $INCY after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 75%.
19/5/2022 NASDAQ (INCY)Short (Entry Price) below the black line and exit (Stop Loss) above the red line. Can take profit at the suggested Target Price.
Entry Price: $74.62
Target Price: $73.86
Stop Loss: $75.89
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 1INCY is featured.
Frequently Asked Questions
The current price of 1INCY is 48.31 EUR — it has increased by 1.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange INCYTE stocks are traded under the ticker 1INCY.
INCYTE is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
1INCY stock is 1.80% volatile and has beta coefficient of 0.84. Check out the list of the most volatile stocks — is INCYTE there?
1INCY earnings for the last quarter are 1.04 EUR per share, whereas the estimation was 0.79 EUR resulting in a 31.93% surprise. The estimated earnings for the next quarter are 1.04 EUR per share. See more details about INCYTE earnings.
INCYTE revenue for the last quarter amounts to 869.39 M EUR despite the estimated figure of 911.59 M EUR. In the next quarter revenue is expected to reach 908.48 M EUR.
Yes, you can track INCYTE financials in yearly and quarterly reports right on TradingView.
1INCY stock has fallen by 1.89% compared to the previous week, the month change is a 8.50% fall, over the last year INCYTE has showed a 2.60% decrease.
1INCY net income for the last quarter is 182.18 M EUR, while the quarter before that showed 162.02 M EUR of net income which accounts for 12.44% change. Track more INCYTE financial stats to get the full picture.
Today INCYTE has the market capitalization of 10.85 B, it has decreased by 2.74% over the last week.
No, 1INCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1INCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INCYTE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 2.52 K employees. See our rating of the largest employees — is INCYTE on this list?
We've gathered analysts' opinions on INCYTE future price: according to them, 1INCY price has a max estimate of 82.30 EUR and a min estimate of 52.37 EUR. Read a more detailed INCYTE forecast: see what analysts think of INCYTE and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INCYTE EBITDA is 665.40 M EUR, and current EBITDA margin is 19.87%. See more stats in INCYTE financial statements.